Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

Family by the Ton Exclusive: Watch Ed Barnes Prep for Weight-Loss Surgery

TLC’s Family by the Ton doesn’t shy away from the most painful moments in people’s journeys to weight loss. The spinoff of the popular My 600-lb Life, airing Wednesday nights, follows a number of families struggling with obesity issues. In this exclusive clip from this week’s episodes, which TLC provided to Men’s Health, star Ed… Read More »